Davies G R, Porra M
Dental School, University of Western Australia.
Aust Dent J. 1994 Aug;39(4):238-41. doi: 10.1111/j.1834-7819.1994.tb04784.x.
Viral hepatitis caused by the hepatitis B virus is a disease which has no oral manifestations but is of direct concern to dental health care workers due to its transmissibility by transfer of minute quantities of infected body fluids from patients with the condition. Many chronic carriers of HBV do not have signs and symptoms of hepatitis and are frequently unaware of the virus they harbour. In recent years immunization against HBV has become possible and a high success rate has been achieved in inducing immunity against HBV in dental health care workers who have completed an immunization programme. When the HBV vaccines were introduced to widespread clinical use in the 1980s it was optimistically predicted that immunity conferred by the vaccines would be for ten years. Recent research has cast severe doubts on this optimism and clinical trials have indicated that the immunity may be short-lived and varies between individuals. Longevity of immunity is dependent upon antibody levels attained by the immunization programme. Post-immunization antibody levels can be utilized as a guide to the longevity of the immunity and hence should serve as a prognostic indicator for timing of booster inoculations.
由乙型肝炎病毒引起的病毒性肝炎是一种没有口腔表现的疾病,但由于患有该疾病的患者通过微量感染体液传播,牙科保健工作者对此直接关注。许多乙肝病毒慢性携带者没有肝炎的体征和症状,并且常常不知道自己携带病毒。近年来,针对乙肝病毒的免疫接种已成为可能,并且在完成免疫接种计划的牙科保健工作者中诱导抗乙肝病毒免疫力方面已取得了很高的成功率。当乙肝疫苗在20世纪80年代广泛应用于临床时,人们乐观地预测疫苗赋予的免疫力将持续十年。最近的研究对这种乐观态度提出了严重质疑,临床试验表明免疫力可能是短暂的,并且因人而异。免疫力的持续时间取决于免疫接种计划所达到的抗体水平。免疫接种后的抗体水平可作为免疫力持续时间的指南,因此应作为加强接种时间的预后指标。